Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the ...
EQS-News: Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements ...
Mainz Biomed Regains Compliance With Nasdaq Listing Rules
Mainz Biomed N.V. (MYNZ), a molecular genetics diagnostic company, announced on Monday, that it has regained compliance with Nasdaq's ...
Nasdaq3d
Mainz Biomed Regains Compliance With Nasdaq Listing Rules
(RTTNews) - Mainz Biomed N.V. (MYNZ), a molecular genetics diagnostic company, announced on Monday, that it has regained compliance with Nasdaq's continued listing requirements. The company ...
Mainz BioMed NV: Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
Mainz Biomed NV (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early ...
PharmiWeb3d
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
BERKELEY, US – MAINZ, Germany – January 27, 2025 — Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of ...